Enzo Says Court Ruling Enables Claim for 'Substantial Damages' Against Life Technologies | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (Genomeweb News) – Enzo Biochem today said that a decision by an appellate court last week that reversed a district court's summary judgment enables the firm to pursue a claim for "substantial damages" against Life Technologies.

Enzo said that the Court of Appeals for the Federal Circuit had vacated the lower court's judgment of invalidity for US Patent Nos. 5,328,824 and 5,449,767.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.